Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alpha Cognition Inc (ACOGF)

Alpha Cognition Inc (ACOGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 56,291
  • Shares Outstanding, K 108,902
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,770 K
  • 60-Month Beta 2.90
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ACOGF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.10
  • Most Recent Earnings $-0.02 on 04/03/24
  • Latest Earnings Date 06/04/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +2,497,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4400 +15.64%
on 05/13/24
0.5319 -4.34%
on 05/03/24
-0.0012 (-0.24%)
since 04/17/24
3-Month
0.4400 +15.64%
on 05/13/24
0.7058 -27.91%
on 03/11/24
-0.0545 (-9.68%)
since 02/16/24
52-Week
0.1401 +263.17%
on 06/21/23
0.7398 -31.22%
on 01/19/24
+0.3122 (+158.80%)
since 05/15/23

Most Recent Stories

More News
Alpha Cognition Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5088 (-1.57%)
Alpha Cognition Provides Private Placement Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“ Alpha Cognition ”, or the “ Company ”), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders,...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5088 (-1.57%)
Alpha Cognition Announces Third Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5088 (-1.57%)
Alpha Cognition Announces Second Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5088 (-1.57%)
Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5088 (-1.57%)
Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5088 (-1.57%)
Alpha Cognition Announces Successful Defense of European Patent Covering ALPHA-0602

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5088 (-1.57%)
Alpha Cognition Announces Positive Data from Pre-Clinical Studies and Discovery of GEM Combinations with Potential for Neurodegenerative Disease Treatment

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders,...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5088 (-1.57%)
Alpha Cognition Announces Grant of Stock Options

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5088 (-1.57%)
Alpha Cognition Announces First Quarter 2022 Results and Company Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5088 (-1.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.

See More

Key Turning Points

3rd Resistance Point 0.5297
2nd Resistance Point 0.5220
1st Resistance Point 0.5154
Last Price 0.5088
1st Support Level 0.5011
2nd Support Level 0.4934
3rd Support Level 0.4868

See More

52-Week High 0.7398
Fibonacci 61.8% 0.5107
Last Price 0.5088
Fibonacci 50% 0.4399
Fibonacci 38.2% 0.3692
52-Week Low 0.1401

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar